A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)

Clinical trial NCT00106145 · COMPLETED

Trial details

NCT number: NCT00106145
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer Other Solid Tumors

Start date: 2005-04-01
Primary completion: 2011-08-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.